ACHIEVE LIFE SCIENCES, INC. 4

Thomas Sellig received a stock option for 25,000 shares at $6.18 and an RSU award for 16,700 shares of Achieve Life Sciences, Inc. common stock as equity compensation.

On July 27, 2026, reporting person Thomas Sellig of Achieve Life Sciences, Inc. received an equity compensation grant consisting of a stock option to purchase 25,000 shares of common stock at an exercise price of $6.18 per share and a restricted stock unit (RSU) award covering 16,700 shares of common stock. Both the option and RSU awards vest 100% on the earlier of July 27, 2027, or the date immediately prior to the issuer’s 2027 annual meeting of stockholders, contingent upon Mr. Sellig’s continued service. Following these grants, Mr. Sellig holds 41,700 shares or share-equivalents in the form of options and RSUs, representing routine director or officer equity compensation rather than an open-market purchase or sale.

Filing Facts

CIK

949858

Ticker

ACHV

Form

4

Source Type

fda

Accession

0001193125-26-324262

Alert Tier

5